Helen Kim

Chief Business Officer

Ms. Kim brings over 20 years of industry experience to NGM. Most recently, Ms. Kim served as Director and chief executive officer of privately held TRF Pharma, Inc. Previously, she was the chief executive officer and President of Kosan Biosciences where she restructured and repositioned the company prior to successfully selling it to Bristol-Myers Squibb in 2008. Ms. Kim's additional industry experience includes executive management positions at Affymax, Onyx Pharmaceuticals, and Chiron Corporation. In addition, Ms. Kim also served as chief program officer for the Gordon and Betty Moore Foundation where she successfully created and implemented initiatives to transform healthcare delivery in acute care hospitals to reduce mortality and morbidities. Ms. Kim received a B.S. in Chemical Engineering from Northwestern University and a M.B.A. from the University of Chicago.